Detection of nucleic acids
US-9273349-B2 · Mar 1, 2016 · US
US11768198B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11768198-B2 |
| Application number | US-202016795467-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 19, 2020 |
| Priority date | Feb 18, 2011 |
| Publication date | Sep 26, 2023 |
| Grant date | Sep 26, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides barcode libraries and methods of making and using them including obtaining a plurality of nucleic acid constructs in which each construct comprises a unique N-mer and a functional N-mer and segregating the constructs into a fluid compartments such that each compartment contains one or more copies of a unique construct. The invention further provides methods for digital PCR and for use of barcode libraries in digital PCR.
Opening claim text (preview).
What is claimed is: 1. A method for protein detection, the method comprising: introducing a protein-specific binding reagent linked to an oligonucleotide barcode to a sample comprising a population of cells; encapsulating the cells in sample droplets such that each sample droplet comprises a single cell and said protein-specific binding reagent by merging droplets containing said cells and said protein-specific binding reagents; and determining the presence of proteins of said cells that are bound to said protein-specific binding reagents. 2. The method of claim 1 , further comprising the step of lysing said cells. 3. The method of claim 1 , wherein said protein-specific binding reagent is selected from an antibody, an aptamer, a nucleic acid-labeled protein. 4. The method of claim 1 , wherein the protein-specific binding reagents are coupled to beads. 5. The method of claim 1 , wherein the protein-specific binding reagents are cleavable from the proteins to which they bind. 6. The method of claim 1 , wherein the proteins are cell-surface proteins. 7. The method of claim 1 , wherein the encapsulating step comprises loading the cells into a microfluidic chip. 8. The method of claim 1 , wherein the protein-specific binding reagents further comprise a universal binding site. 9. The method of claim 1 , further comprising quantifying the proteins. 10. The method of claim 1 , wherein the oligonucleotide barcodes linked to the protein-specific binding reagents have ligation-competent ends and the method includes ligating copies of droplet-identifying barcodes to the oligonucleotide barcodes linked to said protein-specific binding reagents. 11. The method of claim 2 , wherein lysing occurs within said droplets.
by coupling phenotype to genotype, not provided for in other groups of this subclass · CPC title
Production of labelled immunochemicals · CPC title
Nucleotidyl transfering · CPC title
Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title
Immunoassay; Biospecific binding assay; Materials therefor · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.